{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:00:20Z","timestamp":1789887620537,"version":"4.0.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health Career Development","award":["NIAID K23 AI13264801A1"],"award-info":[{"award-number":["NIAID K23 AI13264801A1"]}]},{"DOI":"10.13039\/100001949","name":"American Society of Tropical Medicine and Hygiene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mycobacterium abscessus disease is particularly challenging to treat, given the intrinsic drug resistance of this species and the limited data on which recommendations are based, resulting in a greater reliance on expert opinion. We address several commonly encountered questions and management considerations regarding pulmonary Mycobacterium abscessus disease, including the role of subspecies identification, diagnostic criteria for determining disease, interpretation of drug susceptibility test results, approach to therapy including the need for parenteral antibiotics and the role for new and repurposed drugs, and the use of adjunctive strategies such as airway clearance and surgical resection.<\/jats:p>","DOI":"10.1093\/ofid\/ofz221","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T17:39:46Z","timestamp":1557855586000},"source":"Crossref","is-referenced-by-count":15,"title":["Top Questions in the Diagnosis and Treatment of Pulmonary M. abscessus Disease"],"prefix":"10.1093","volume":"6","author":[{"given":"Ruvandhi R","family":"Nathavitharana","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Strnad","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Oregon Health and Sciences University, Portland, Oregon"},{"name":"Epidemiology Programs, Oregon Health and Sciences University and Portland State University School of Public Health, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A","family":"Lederer","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maunank","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland"},{"name":"Baltimore City Health Department, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio M","family":"Hurtado","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Global Health Committee, Ethiopia and Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"2020081003571679400_CIT0001","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/CMR.15.4.716-746.2002","article-title":"Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria","volume":"15","author":"Brown-Elliott","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"2020081003571679400_CIT0002","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081003571679400_CIT0003","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/2109.141634","article-title":"Mycobacterium abscessus complex infections in humans","volume":"21","author":"Lee","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2020081003571679400_CIT0004","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.5588\/ijtld.14.0134","article-title":"Advances in the management of pulmonary disease due to Mycobacterium abscessus complex","volume":"18","author":"Koh","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020081003571679400_CIT0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.chest.2017.04.166","article-title":"Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis","volume":"152","author":"Diel","year":"2017","journal-title":"Chest"},{"key":"2020081003571679400_CIT0006","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/jpids\/piy047","article-title":"Mycobacterium abscessus infections in children: a review of current literature","volume":"7","author":"Lamb","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2020081003571679400_CIT0007","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1651494","article-title":"Treatment of Mycobacterium abscessus complex","volume":"39","author":"Strnad","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"2020081003571679400_CIT0008","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081003571679400_CIT0009","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.ajic.2016.06.019","article-title":"Pseudooutbreak of rapidly growing mycobacteria due to Mycobacterium abscessus subsp bolletii in a digestive and respiratory endoscopy unit caused by the same clone as that of a countrywide outbreak","volume":"44","author":"Guimar\u00e3es","year":"2016","journal-title":"Am J Infect Control"},{"key":"2020081003571679400_CIT0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/524328","article-title":"Pseudo-outbreak of Mycobacterium abscessus infection caused by laboratory contamination","volume":"29","author":"Blossom","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020081003571679400_CIT0011","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/QCO.0000000000000104","article-title":"Mycobacterium abscessus: challenges in diagnosis and treatment","volume":"27","author":"Benwill","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"2020081003571679400_CIT0012","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2015-207983","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous Mycobacteria in individuals with cystic fibrosis: executive summary","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"2020081003571679400_CIT0013","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1471-2164-15-359","article-title":"Genome analysis reveals three genomospecies in Mycobacterium abscessus","volume":"15","author":"Sassi","year":"2014","journal-title":"BMC Genomics"},{"key":"2020081003571679400_CIT0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081003571679400_CIT0015","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01480-17","article-title":"Evaluation of whole-genome sequencing for mycobacterial species identification and drug susceptibility testing in a clinical setting: a large-scale prospective assessment of performance against line probe assays and phenotyping","volume":"56","author":"Quan","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2020081003571679400_CIT0016","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Brown-Elliott","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2020081003571679400_CIT0017","volume-title":"Susceptibility Testing of Mycobacteria N, and Other Aerobic Actinomycetes","author":"CLSI 2018","edition":"3"},{"key":"2020081003571679400_CIT0018","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/AAC.03112-15","article-title":"Tigecycline is highly efficacious against Mycobacterium abscessus pulmonary disease","volume":"60","author":"Ferro","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081003571679400_CIT0019","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1513\/AnnalsATS.201501-015OI","article-title":"Mycobacterium abscessus. \u201cPleased to meet you, hope you guess my name.\u201d","volume":"12","author":"Griffith","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2020081003571679400_CIT0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01204-18","article-title":"Whole-genome sequencing for predicting clarithromycin resistance in Mycobacterium abscessus","author":"Lipworth","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081003571679400_CIT0021","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciw724","article-title":"Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease","volume":"64","author":"Koh","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020081003571679400_CIT0022","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciw723","article-title":"Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense","volume":"64","author":"Park","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020081003571679400_CIT0023","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3201\/eid2203.150828","article-title":"Treatment of Mycobacterium abscessus infection","volume":"22","author":"Novosad","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2020081003571679400_CIT0024","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13084","article-title":"Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience","author":"Perez","year":"2019 29:13084","journal-title":"Transpl Infect Dis"},{"key":"2020081003571679400_CIT0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.201111-2005OC","article-title":"Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance","volume":"186","author":"Choi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081003571679400_CIT0026","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"2020081003571679400_CIT0027","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jac\/dku431","article-title":"Time-kill kinetics of antibiotics active against rapidly growing mycobacteria","volume":"70","author":"Ferro","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020081003571679400_CIT0028","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020081003571679400_CIT0029","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3389\/fmicb.2018.02273","article-title":"Mycobacterium abscessus and \u03b2-lactams: emerging insights and potential opportunities","volume":"9","author":"Story-Roller","year":"2018","journal-title":"Front Microbiol"},{"key":"2020081003571679400_CIT0030","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2020081003571679400_CIT0031","doi-asserted-by":"crossref","first-page":"O297","DOI":"10.1111\/1469-0691.12405","article-title":"In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex","volume":"20","author":"Lavollay","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020081003571679400_CIT0032","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00866-17","article-title":"Mycobacterium abscessus l,d-transpeptidases are susceptible to inactivation by carbapenems and cephalosporins but not penicillins","volume":"61","author":"Kumar","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081003571679400_CIT0033","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2020081003571679400_CIT0034","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2017.04.175","article-title":"Safety and effectiveness of clofazimine for primary and refractory nontuberculous mycobacterial infection","volume":"152","author":"Martiniano","year":"2017","journal-title":"Chest"},{"key":"2020081003571679400_CIT0035","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02052-16","article-title":"Clofazimine-containing regimen for the treatment of Mycobacterium abscessus lung disease","volume":"61","author":"Yang","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"2020081003571679400_CIT0036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5588\/ijtld.15.0068","article-title":"Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea","volume":"20","author":"Kim","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020081003571679400_CIT0037","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.diagmicrobio.2017.11.001","article-title":"In vitro activity of tedizolid against the Mycobacterium abscessus complex","volume":"90","author":"Compain","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020081003571679400_CIT0038","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.14-2764","article-title":"Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease","volume":"148","author":"Philley","year":"2015","journal-title":"Chest"},{"key":"2020081003571679400_CIT0039","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/JCM.00274-17","article-title":"In vitro susceptibility testing of tedizolid against nontuberculous mycobacteria","volume":"55","author":"Brown-Elliott","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2020081003571679400_CIT0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00011-18","article-title":"Amikacin inhalation as salvage therapy for refractory nontuberculous mycobacterial lung disease","volume":"62","author":"Jhun","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"2020081003571679400_CIT0041","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease","volume":"195","author":"Olivier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081003571679400_CIT0042","article-title":"Effects of chest physical therapy in patients with non-tuberculous mycobacteria","volume":"4: 065","author":"Basavaraj","year":"","journal-title":"Int J Respir Pulm Med"},{"key":"2020081003571679400_CIT0043","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","article-title":"Bronchiectasis: new therapies and new perspectives","volume":"6","author":"Chalmers","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2020081003571679400_CIT0044","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciq237","article-title":"Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease","volume":"52","author":"Jarand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020081003571679400_CIT0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12879-015-0823-1","article-title":"Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease","volume":"15","author":"Kang","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2020081003571679400_CIT0046","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccm.2014.11.004","article-title":"Surgical approach to pulmonary nontuberculous mycobacterial infections","volume":"36","author":"Mitchell","year":"2015","journal-title":"Clin Chest Med"},{"key":"2020081003571679400_CIT0047","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.athoracsur.2012.01.012","article-title":"Thoracoscopic lobectomy and segmentectomy for infectious lung disease","volume":"93","author":"Mitchell","year":"2012","journal-title":"Ann Thorac Surg"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofz221\/28648008\/ofz221.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/7\/ofz221\/33589898\/ofz221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/7\/ofz221\/33589898\/ofz221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T01:00:25Z","timestamp":1663462825000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz221\/5489352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz221","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,5,14]]},"article-number":"ofz221"}}